Methotrexate pneumonitis precipitated by switching from oral to parenteral administration

Rheumatology (Oxford). 2008 Jan;47(1):109-10. doi: 10.1093/rheumatology/kem230. Epub 2007 Nov 27.

Authors

K Collins¹, H Aspey, A Todd, V Saravanan, M Rynne, C Kelly

Affiliation

¹ Rheumatology and General Medicine, Queen Elizabeth Hospital, Gateshead, Tyne and Wear, UK.

PMID: 18042567
DOI: 10.1093/rheumatology/kem230

No abstract available

Publication types

Case Reports

MeSH terms

Administration, Oral
Aged
Arthritis / complications*
Arthritis / drug therapy
Arthritis / pathology
Dose-Response Relationship, Drug
Drug Therapy, Combination
Female
Glucocorticoids / therapeutic use
Humans
Immunosuppressive Agents / administration & dosage
Immunosuppressive Agents / adverse effects*
Injections, Subcutaneous
Leucovorin / therapeutic use
Methotrexate / administration & dosage
Methotrexate / adverse effects*
Oxygen Inhalation Therapy
Pneumonia / chemically induced*
Pneumonia / drug therapy
Pneumonia / pathology
Treatment Outcome

Substances

Glucocorticoids
Immunosuppressive Agents
Leucovorin
Methotrexate